CD4+ Cell Count 6 Years after Commencement of Highly Active Antiretroviral Therapy in Persons with Sustained Virologic Suppression
Top Cited Papers
Open Access
- 1 February 2007
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 44 (3), 441-446
- https://doi.org/10.1086/510746
Abstract
Background.Sustained suppression of the human immunodeficiency virus (HIV) type 1 RNA load with the use of highly active antiretroviral therapy (HAARKeywords
This publication has 15 references indexed in Scilit:
- Immunologic Response to Antiretroviral Therapy in Hepatitis C Virus–Coinfected Adults in a Population‐Based HIV/AIDS Treatment ProgramThe Journal of Infectious Diseases, 2006
- Factors Influencing Increases in CD4 Cell Counts of HIV?Positive Persons Receiving Long?Term Highly Active Antiretroviral TherapyThe Journal of Infectious Diseases, 2004
- Long-Term CD4+ T-Cell Response to Highly Active Antiretroviral Therapy According to Baseline CD4+ T-Cell CountJAIDS Journal of Acquired Immune Deficiency Syndromes, 2004
- Impact of viral hepatitis co-infection on response to antiretroviral therapy and HIV disease progression in the HIV-NAT cohortAIDS, 2004
- Impact of 5 years of maximally successful highly active antiretroviral therapy on CD4 cell count and HIV-1 DNA levelAIDS, 2004
- Continued CD4 cell count increases in HIV-infected adults experiencing 4 years of viral suppression on antiretroviral therapyAIDS, 2003
- Factors associated with a reduced CD4 lymphocyte count response to HAART despite full viral suppression in the EuroSIDA studyHIV Medicine, 2003
- Longitudinal assessment of the effects of drug and alcohol abuse on HIV-1 treatment outcomes in an urban clinicAIDS, 2002
- The Naive CD4+ Count in HIV-1-infected Patients at Time of Initiation of Highly Active Antiretroviral Therapy is Strongly Associated with the Level of Immunological RecoveryScandinavian Journal of Infectious Diseases, 2002
- Increase and Plateau of CD4 T-Cell Counts in the 3½ Years After Initiation of Potent Antiretroviral TherapyJAIDS Journal of Acquired Immune Deficiency Syndromes, 2001